Andreas Theuer
Overview
Explore the profile of Andreas Theuer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
148
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bold G, Schnell C, Furet P, McSheehy P, Bruggen J, Mestan J, et al.
J Med Chem
. 2015 Dec;
59(1):132-46.
PMID: 26629594
This paper describes the identification of 6-(pyrimidin-4-yloxy)-naphthalene-1-carboxamides as a new class of potent and selective human vascular endothelial growth factor receptor 2 (VEGFR2) tyrosine kinase inhibitors. In biochemical and cellular...
2.
Sini P, Samarzija I, Baffert F, Littlewood-Evans A, Schnell C, Theuer A, et al.
Cancer Res
. 2008 Mar;
68(5):1581-92.
PMID: 18316624
Vascular endothelial growth factor receptors (VEGFR) have important roles in cancer, affecting blood and lymphatic vessel functionality as well as tumor cells themselves. We compared the efficacy of a VEGFR...
3.
LaMontagne K, Littlewood-Evans A, Schnell C, OReilly T, Wyder L, Sanchez T, et al.
Cancer Res
. 2006 Jan;
66(1):221-31.
PMID: 16397235
FTY720, a potent immunomodulator, becomes phosphorylated in vivo (FTY-P) and interacts with sphingosine-1-phosphate (S1P) receptors. Recent studies showed that FTY-P affects vascular endothelial growth factor (VEGF)-induced vascular permeability, an important...